Tag: NASDAQ:TRIV

Finance

Hot News : CBS Corporation (NYSE:CBS), Bitauto Holdings Limited (NYSE:BITA), Royal Bank of Canada (NYSE:RY), Ceragon Networks Ltd. (NASDAQ:CRNT), TriVascular Technologies (NASDAQ:TRIV)

A day after HBO announced their upcoming stand-alone streaming service, CBS Corporation (NYSE:CBS) has announced the launch of CBS All Access – a new digital subscription video on demand and Nielsen-measured live streaming service for the CBS Television Network. CBS Corporation (NYSE:CBS) belongs to Services sector. Its net profit margin is 13.10% and weekly performance is 9.32%. On last trading day company shares ended up … Continue reading Hot News : CBS Corporation (NYSE:CBS), Bitauto Holdings Limited (NYSE:BITA), Royal Bank of Canada (NYSE:RY), Ceragon Networks Ltd. (NASDAQ:CRNT), TriVascular Technologies (NASDAQ:TRIV)

Mark Doerr
Finance

Bullish Stocks: Borderfree (NASDAQ:BRDR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), K2M Group Holdings Inc (NASDAQ:KTWO), Arc Logistics Partners LP (NYSE:ARCX)

As of late, it has definitely been a great time to be an investor in Borderfree Inc (NASDAQ:BRDR). The stock has moved higher by 22.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path. Borderfree Inc (NASDAQ:BRDR) stock performance was … Continue reading Bullish Stocks: Borderfree (NASDAQ:BRDR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), K2M Group Holdings Inc (NASDAQ:KTWO), Arc Logistics Partners LP (NYSE:ARCX)

Kevin Long
Finance

Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and finished the day at $4.02. Traded volume was 9.62million shares … Continue reading Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Kristen Barton